Cigna and Aetna among world’s most ‘valuable’ healthcare brands
International health insurers Aetna and Cigna are among the world’s most valuable healthcare brands, according to research by consultancy Brand Finance.
Aetna was ranked third...
Circle Health launches hospital in Shanghai
At long last, UK healthcare provider Circle Health has opened its first Chinese hospital in Shanghai. The Rmb200m (£23m) brand new facility is the...
Deals volumes slowing but healthcare remains resilient, says report
The global healthcare market remains resilient with near-record levels of deal-making reported in 2022 despite a challenging macro-economic and geopolitical environment, according to a...
Colosseum Dental Group appoints CEO and CFO
Pan European dentistry provider Colosseum Dental Group has appointed Stefan Nilsson as its chief executive officer and Daniel Fehr as its chief financial officer.
Nilsson,...
Ramsay ups bid for Capio
Ramsay Health Care has upped its offer to buy pan-European healthcare company Capio AB (Capio) from €661m to €783m.
The Australian healthcare giant previously resisted...
NMC Health reiterates guidance after rating downgraded
NMC Health has reiterated its guidance for 2018 and 2019, saying management remains comfortable with anticipated year-on-year EBITDA growth of 36% in 2018 and...
New general manager at Bupa Global Asia Pacific
Jonathan Quach has been appointed general manager of Bupa Global Asia Pacific (BGAPAC) at Bupa Global, the international health insurance arm of Bupa.
Quach previously led business...
Australian government to pilot Care Protect monitoring system
Care Protect surveillance and monitoring systems will be piloted in five state-owned care homes in Australia.
The South Australian government is investing A$500,000 (£273,718) to...
Earnings at UDG Healthcare grow 22%
International healthcare services provider UDG Healthcare reported today that revenue was 5% ahead of last year at constant currency rates to reach $1,315.2m (£1,031.6m)...
Spain: Ysios Capital targets 15 investments from close of €216m third fund
Spain-based biotech venture capital firm, Ysios Capital, has closed its third fund, Ysios BioFund 3 (YBF 3) at €216m (US$264m).
Its largest fund to date,...